MYC and Huntington disease: Globally, by Ingenuity Pathway Analysis, the PNGT3-high hits featured the activation of the EIF2 pathway (p = 5.64e−09) microRNA biogenesis (p = 7.93e−08) and Huntington’s disease signaling (p = 5.73e−07) pathways, and the MYC transcriptional program activation (p = 5.3e−15).